Utilization of this particular methodology facilitated the identification of exceedingly minute quantities of amyloid‐beta and tau proteins in cerebrospinal fluid, thereby establishing the potential of Au NPs as a viable diagnostic instrument for AD. The gene discussed is MAPT; the disease is Alzheimer disease.